William Regine is an Oncology physician affiliated with University of Maryland, Baltimore. OpenAlex indexes 423 publications with 15,558 citations (h-index 56); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Radiation Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
22 S Greene St
Gudelsky Basement
Baltimore, MD 212011544
Telephone
410-328-3037Registry record last updated 29 Apr 2008.
Clinical trials
- Prospective Patient Registry for Radiation Oncology Techniques and Quality
Sponsor: University of Maryland, Baltimore
- Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC)
Sponsor: University of Maryland, Baltimore
- Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
Sponsor: Radiation Therapy Oncology Group
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PROGENICS PHARMACEUTICALS, INC.Program year20251 payment
- BIOPROTECT MEDICAL, INC.Program year20251 payment
- Siemens Medical Solutions USA, Inc.Program year202413 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Understanding High-Dose, Ultra-High Dose Rate, and Spatially Fractionated Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics
2020 - Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head
American Journal of Clinical Oncology
2020 - Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation
Radiotherapy and Oncology
2017 - Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials
International Journal of Radiation Oncology*Biology*Physics
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Kittner
University of Maryland, Baltimore
Edward Sausville, MD
University of Maryland, Baltimore
Aloke Finn, MD
University of Maryland, Baltimore
Christopher Plowe, MD
University of Maryland, Baltimore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”